CO[C@]12C[C@H](CNC(=O)c3cc(Br)c(Br)[nH]3)O[C@H]1NC(=O)N2
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?